What Is Sermorelin? Uses, Benefits, Risks, and How It Works

Table of Contents

Sermorelin is a synthetic peptide that works as a growth hormone-releasing hormone (GHRH) analog. In plain terms, it copies a natural signal that tells the pituitary gland to release the body’s own growth hormone.¹ It does not supply growth hormone directly. Since the discontinuation of branded Geref, sermorelin is now only available in the U.S. as a compounded product.^2,3 This means that it is prescribed by licensed clinicians and prepared by compounding pharmacies, rather than sold as an FDA-approved branded drug.³

Interest in sermorelin has grown alongside telehealth clinics, longevity medicine, and hormone optimization practices. This is reflected in the widespread online discussion of peptide therapy.⁴ Many of these venues frame sermorelin as a gentler alternative to human growth hormone, and that framing has driven much of its visibility. The clinical picture is more measured than the marketing.⁵

Expectations should be realistic. There is limited evidence supporting sermorelin for general wellness goals, and the peptide is not the same as growth hormone replacement.⁶ Results vary from person to person, and medical oversight, including baseline testing and follow-up, matters for both safety and appropriateness.⁷

Medical Disclaimer: This article is for informational and educational purposes only and is not medical advice. At the time of writing, sermorelin is available only through a licensed clinician and a compounding pharmacy. Compounded peptide preparations are not FDA-approved and may vary in quality, purity, and dosing. Consult a qualified healthcare professional before considering sermorelin or any prescription therapy.

At a Glance

Here are a few highlights about sermorelin^7,8,9,10:

Drug class: GHRH analog and growth hormone secretagogue
What it does: stimulates the pituitary gland to release growth hormone
Delivery: subcutaneous injection
Typical timing: nighttime, near the body’s natural GH pulse
Common monitoring labs: May include IGF-1, fasting glucose, lipids, thyroid panel
Common side effects: injection-site irritation, flushing, headache, dizziness
FDA status: original branded product discontinued; current use is compounded
Important considerations: active cancer, pregnancy, untreated thyroid disorders, uncontrolled diabetes, medical history, and other individualized risk factors.

Sermorelin Explained

Sermorelin is a peptide, which is a short chain of amino acids. Amino acids are the same building blocks that form proteins.¹¹ Sermorelin matches the active part of growth hormone-releasing hormone, the natural signal the body uses to prompt growth hormone production. Because it copies this signal, sermorelin is classified as a growth hormone secretagogue. That term means a substance that prompts the body to release its own growth hormone, rather than adding growth hormone from outside.^9,10

Sermorelin was originally developed as an approved pharmaceutical. The branded product Geref was approved by the U.S. Food and Drug Administration and used in clinical settings, including the evaluation and treatment of growth hormone deficiency in children. While Geref was later discontinued from the U.S. market, it wasn’t because of concerns about safety or effectiveness.¹²

Because the branded product is no longer available, nearly all current sermorelin use happens through compounded preparations.^6,8,10 A compounded medication is custom-prepared by a pharmacy rather than manufactured and approved as a finished drug product.³ Patients who encounter sermorelin today are almost always receiving a compounded version obtained through a prescribing clinician.

How Sermorelin Works

Sermorelin works within the endocrine system, the network of glands and hormones that regulates functions such as growth, metabolism, and reproduction through chemical messengers carried in the blood.^13,14 Understanding how it works takes a short tour of the glands and signals involved.

Hypothalamus and pituitary gland basics

The hypothalamus is a small region at the base of the brain that helps coordinate hormone signals and connects the nervous system to the endocrine system. The pituitary gland sits just below it and releases hormones that direct other glands and tissues. The hypothalamus gives instructions and the pituitary carries them out by producing and releasing the hormones.¹⁴

What GHRH is

Growth hormone-releasing hormone (GHRH) is the natural signal the hypothalamus sends to the pituitary to trigger growth hormone (GH) production and release. When GHRH reaches receptors on pituitary cells, those cells respond by releasing growth hormone into the bloodstream. GHRH is the on switch for this part of the growth hormone pathway.¹³

How sermorelin mimics GHRH to stimulate GH release

Sermorelin is built to resemble the active part of GHRH, so it binds the same pituitary receptors and prompts the same response. The result is that the pituitary releases growth hormone the body makes itself. This is the central difference between sermorelin and growth hormone replacement, which the next major section explains in detail.^9,10

IGF-1 and downstream signaling

Once growth hormone enters the bloodstream, much of its effect is carried out through insulin-like growth factor-1, or IGF-1. IGF-1 is a hormone made mostly by the liver in response to growth hormone. It carries out many of growth hormone’s effects on tissues and stays more stable in the blood than growth hormone itself. For that reason, doctors often measure IGF-1 to gauge growth hormone activity instead of measuring growth hormone directly.^15,16

Pulsatile GH release and why timing matters

The body does not release growth hormone at a steady level. It releases it in bursts, a pattern called pulsatile secretion, with the largest bursts usually happening during deep sleep at night.¹³ GHRH drives these pulses, and so bedtime dosing is intended to reinforce the pituitary signal when a natural burst would occur.¹³

Sermorelin vs HGH

The core difference is how each one works. Sermorelin stimulates the pituitary to release the body’s own growth hormone.¹ Human growth hormone (HGH) supplies growth hormone directly instead. Sermorelin works through the existing growth hormone pathway described in How Sermorelin Works, whereas HGH bypasses that entire pathway.^6,10

This difference matters inside the body. Because sermorelin acts on the pituitary, it leaves the body’s natural feedback controls in place. Those controls act as brakes that limit how much growth hormone is released. HGH does not rely on those brakes, because it adds hormone regardless of the body’s own signaling.^6,10

A common claim is that sermorelin is therefore safer than HGH. This is a proposition based on how the two work, not a proven conclusion. No large head-to-head trial has compared long-term suppression risk between sermorelin and HGH in healthy adults, and much of the safer framing comes from clinic marketing rather than controlled research.^7,10 The frequent description of sermorelin as a natural HGH replacement is an oversimplification, because sermorelin and HGH are not the same drug and do not work the same way.^6,10

Feature	Sermorelin	Human Growth Hormone (HGH)
Action^6,10	Stimulates the pituitary to release the body’s own growth hormone	Replaces growth hormone directly
Feedback loop^6,10	Natural feedback brakes preserved	Natural feedback bypassed
Monitoring^10,17	IGF-1, glucose, lipids, thyroid, adrenal function	IGF-1, glucose, lipids, thyroid, adrenal function
FDA status^8,17,18	Branded product discontinued; current use compounded and not FDA-approved	FDA-approved for specific indications, including pediatric and adult growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, chronic renal insufficiency in children, and other growth-related conditions

Uses, Evidence, and Realistic Expectations

Sermorelin’s uses fall into two categories: the narrow clinical role it was approved for, and the much broader off-label use that dominates today. The evidence behind each is very different, and anecdotes and marketing claims are easy to mistake for research.

Historical FDA-approved use in pediatric growth hormone deficiency

The approved clinical role for sermorelin centered on growth hormone deficiency. It was used as a diagnostic agent to assess how well the pituitary works, and in treatment for children with deficiency.^8,19 This was a narrow, test-confirmed medical use, very different from the general-wellness uses that dominate current online discussion.^4,7

Current off-label and telehealth interest areas

Most present-day interest is off-label and clusters around sleep quality, recovery, body composition, and energy. Some users report feeling better in these areas, and the biological reasoning is connected to growth hormone’s known role in the body. But these interest areas reflect why people seek sermorelin out, not proof that it reliably delivers these results.^4,5,6,7

What evidence does and does not show

It helps to separate three kinds of claims.

Anecdotal reports describe personal experiences, but they are not controlled and cannot prove cause and effect.²⁰
Advertising phrases like ‘clinically studied’ indicate only that a product was tested, not that it was shown to work.²¹
Peer-reviewed evidence for sermorelin in healthy adults is limited, and claims about anti-aging benefits are not supported by strong trials.⁴ Reported effects on body composition and muscle-building claims are often inconsistent and based on limited data.^4,5,6,7

Why outcomes vary and why lifestyle factors still matter

Sustainable changes often require lifestyle changes, like⁴:

Adequate protein intake
Caloric restriction
Good sleep habits
Resistance training
Stress management

Also, the quality and composition of different sermorelin preparations on the market can vary.⁷ These factors help explain why two people may report very different experiences.

Side Effects and Risks

This section covers side effects in detail. Sermorelin is generally reported to be well tolerated in clinical settings, but it is a hormonally active prescription product and carries real risks that call for monitoring.¹⁰

Common side effects^6,10,22

Injection-site irritation, including redness, swelling, or discomfort
Flushing
Headache
Dizziness

Less common but important concerns^10,22

Hypersensitivity or allergic-type reactions (like itching or troubling swallowing)
Persistent or worsening headaches that do not resolve

Seek medical attention immediately if you experience any symptoms of an allergic reaction. Reach out to your prescribing clinician about any new or worsening symptom that concerns you.

Fluid retention and metabolic considerations

Growth hormone activity can cause fluid retention, which may show up as mild swelling or joint discomfort. Growth hormone activity also affects metabolism, including how the body handles blood sugar, a topic continued in the next subsection.⁶

Blood sugar considerations

Because growth hormone can reduce insulin sensitivity, sermorelin may affect blood sugar control. It is especially relevant for people with diabetes or prediabetes, and fasting glucose is part of standard monitoring.^6,10

Potential endocrine complications

Because sermorelin acts on the pituitary, it affects a system that regulates several hormones.^12,14 Sustained over-stimulation could, in theory, push IGF-1 above age-appropriate levels, which is why monitoring exists. People with pituitary disorders need particular caution.¹⁰

Who Sermorelin Is For

The established clinical use of sermorelin is the evaluation and treatment of growth hormone deficiency confirmed by testing.^8,19 Its role in healthy adults is not established, and uses related to energy, sleep, recovery, and body composition have limited supporting evidence.^4,5,6,7

These are real reasons people seek it out, but they are not established uses. The right next step is a clinical evaluation, and an endocrinologist is a reasonable place to start. The fact that sermorelin is available online does not, by itself, mean it is appropriate or safe for any given person.⁷

Sermorelin should not be used in the following situations¹⁰:

Pregnancy or breastfeeding
Active or recent cancer
Untreated thyroid disorders
Uncontrolled diabetes

Individualized evaluation matters because hormone therapy interacts with a person’s full medical picture, including existing conditions, medications, and baseline lab values. A legitimate clinical evaluation usually includes a detailed medical history, a discussion of goals and risks, and baseline lab testing before any prescription is considered. This lets a clinician decide whether therapy is medically reasonable and set reference values for monitoring.¹⁰

Valid telehealth prescribing requires a provider-patient relationship built on an adequate history and examination before any drug is prescribed.²³ A provider willing to prescribe sermorelin without reviewing a medical history is therefore a meaningful red flag. Responsible prescribing depends on knowing whether there is a measurable basis for treatment and whether any contraindications are present.¹⁰ Easy access should not be mistaken for clinical appropriateness.

Dosing, Injections, and Lab Monitoring

This section describes general patterns only. It does not provide specific doses or titration instructions, which must come from a prescribing clinician.

General dosing frameworks

Sermorelin is often given by subcutaneous injection, meaning into the tissue just under the skin.^7,10 The prescriber sets the dose individually, based on the patient’s evaluation and monitoring.¹⁰ Specific amounts and schedules are outside the scope of this article.

Why nighttime injection timing is typically discussed

Bedtime dosing comes up often because the body’s largest natural growth hormone bursts happen during deep sleep, the pulsatile pattern described in How Sermorelin Works. Lining up the dose with this rhythm is the reasoning behind nighttime timing.¹⁰

Lab monitoring: IGF-1, metabolic panel, thyroid panel

Standard monitoring generally includes IGF-1 to assess growth hormone activity, a metabolic panel that includes fasting glucose and lipids, and a thyroid panel. Baseline values taken before starting allow a meaningful comparison over time.¹⁰

Why follow-up testing matters and how often it typically occurs

Follow-up testing checks whether IGF-1 stays within age-appropriate ranges and whether glucose or other markers are shifting. The clinician sets the testing schedule, often with an early check after starting and periodic checks after that. Ongoing monitoring is part of safe use, not an optional add-on.¹⁰

Compounded Sermorelin and Telehealth Prescribing

This section covers regulatory status, compounding, and telehealth realities.

Is sermorelin FDA-approved?

The nuance matters here. Geref (the original branded sermorelin product) was FDA-approved but has been discontinued. Current use relies on compounded preparations, which are not FDA-approved drugs. So sermorelin once existed as an approved product, but the sermorelin available today is not an FDA-approved drug.^2,3,6,8,10

What “compounded” means

A compounded medication is prepared by a pharmacy for a specific need, rather than FDA-approved as a finished product and mass-produced.² Compounding happens through two main types of facilities. A 503A pharmacy compounds medications for individual patients based on a prescription. A 503B outsourcing facility makes larger batches under stricter federal oversight and can supply healthcare providers.³ Neither type produces an FDA-approved version of sermorelin; the compounded preparation itself stays non-approved.^6,8,10

Quality variability concerns

Because compounded products do not go through the same premarket approval and standardized manufacturing as approved drugs, quality, purity, and consistency can vary from one source to another.^2,7 This variability is one reason it may be important to know the compounding source.

Why peptide regulation remains controversial

Peptide compounding has drawn more regulatory attention, and the status of various peptides has shifted as the FDA has reviewed which substances are eligible for compounding. This changing landscape adds uncertainty and underscores why oversight by a licensed clinician matters.²⁴

Telehealth prescribing variability and questions to ask providers

Telehealth has made sermorelin easier to access, but practices vary widely in quality and rigor.^7,10 You can evaluate a provider by asking specific questions: Where is the medication sourced, and which compounding pharmacy is used? What level of licensed clinician oversight is involved? How often is follow-up scheduled? What lab monitoring is required before and during therapy? How are side effects monitored and managed?

Watch for: Telehealth clinics that guarantee a prescription before any evaluation, refuse to disclose their compounding pharmacy partner, skip baseline lab work, or market sermorelin with anti-aging or guaranteed-result language. Clinicians have a professional responsibility to prescribe only when medically appropriate.^10,23

Conclusion

Sermorelin stimulates the pituitary to release the body’s own growth hormone, rather than replacing it the way HGH does.^6,9,10 The evidence base is mixed, real differences in outcomes exist between people, and medical oversight is central to using it responsibly.^4,5,6,7,10

Frequently Asked Questions

No, sermorelin has no consistent or direct effect on testosterone. Any indirect effects through changes in IGF-1 or body composition are speculative and not established by reliable evidence.⁹

Sermorelin has a short half-life of roughly 11 to 12 minutes.¹ However, its downstream physiological effects last longer.⁹

No. The World Anti-Doping Agency prohibits growth hormone secretagogues, including sermorelin, both in and out of competition.²⁵

A rise in IGF-1 is expected, since the goal is increased growth hormone activity.¹⁰ How to interpret it depends on the baseline, the size of the change, and the clinical context, and values should stay within age-appropriate reference ranges.^10,26,27

Because sermorelin works through the body’s own growth hormone feedback system rather than supplying hormone from outside, stopping it is thought to be lower-risk than stopping HGH. This is based on how the two work, not on direct head-to-head study. Even so, any change should be coordinated with the prescribing clinician.¹⁰

The most relevant interaction categories are glucocorticoids, thyroid medications, and insulin or other diabetes drugs, because these affect or are affected by growth hormone signaling. A full medication review at intake is standard practice.¹⁰

References

National Center for Biotechnology Information. PubChem Compound Summary for CID 16132413, Sermorelin. Accessed July 8, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/sermorelin
Food and Drug Administration. Determination that GEREF (sermorelin acetate) injection, 0.5 milligrams base/vial and 1.0 milligrams base/vial, and GEREF (sermorelin acetate) injection, 0.05 milligrams base/amp, were not withdrawn from sale for reasons of safety or effectiveness. Federal Register. 2013;78(42):14095-14096. Accessed July 8, 2026. https://www.federalregister.gov/documents/2013/03/04/2013-04827/determination-that-geref-sermorelin-acetate-injection-05-milligrams-basevial-and-10-milligrams
US Food and Drug Administration. Compounding and the FDA: questions and answers. Updated September 16, 2025. Accessed July 8, 2026. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
Pharmacy Times. Peptide therapy for weight loss: separating clinical promise from social media hype. Published June 9, 2026. Accessed July 8, 2026. https://www.pharmacytimes.com/view/peptide-therapy-for-weight-loss-separating-clinical-promise-from-social-media-hype
Dodge D. The internet loves peptide therapy. Is it really a miracle cure? The New York Times. November 18, 2025. Accessed July 8, 2026. https://www.nytimes.com/2025/11/18/well/live/peptide-therapy-skin-muscle-longevity.html
US Anti-Doping Agency. What should athletes know about sermorelin? Spirit of Sport. Published June 30, 2025. Accessed July 8, 2026. https://www.usada.org/spirit-of-sport/athletes-know-sermorelin/
Dominikowski A, Rękoś Z, Olejarz M, Szczepanek-Parulska E, Domin R, RuchaŁa M. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. Front Endocrinol (Lausanne). 2026;17:1822475. Published 2026 Jun 18. Accessed July 8, 2026. doi:10.3389/fendo.2026.1822475 https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2026.1822475/full
University of Maryland, Baltimore. Sermorelin Acetate: Summary Report. UMB Digital Archive; 2020. Accessed July 8, 2026. https://archive.hshsl.umaryland.edu/entities/publication/fc0d2c27-77e7-4ada-ad12-32162c4d614b
Sinha DK, Balasubramanian A, Tatem AJ, et al. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020;9(Suppl 2):S149-S159. Accessed July 8, 2026. doi:10.21037/tau.2019.11.30 https://pmc.ncbi.nlm.nih.gov/articles/pmc7108996/
Testing.com. Sermorelin treatment overview. Updated June 1, 2026. Accessed July 8, 2026. https://www.testing.com/treatments/sermorelin/
National Human Genome Research Institute. Talking glossary of genetic terms: peptide. Updated July 8, 2026. Accessed July 8, 2026. https://www.genome.gov/genetics-glossary/peptide
Ishida J, Saitoh M, Ebner N, Springer J, Anker SD, von Haehling S. Growth hormone secretagogues: history, mechanism of action, and clinical development. JCSM Rapid Commun. 2020;3(1):25-37. doi:10.1002/rco2.9.
Olarescu NC, Gunawardane K, Hanson TK, et al. Normal Physiology of Growth Hormone in Normal Adults. [Updated 2025 Apr 18]. In: Feingold KR, Adler RA, Ahmed SF, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279056/
Cleveland Clinic. Endocrine system: what is it, functions, organs & diseases. Updated November 22, 2023. Accessed July 8, 2026. https://my.clevelandclinic.org/health/body/21201-endocrine-system
MedlinePlus. IGF-1 (insulin-like growth factor-1) test. National Library of Medicine. Updated September 24, 2024. Accessed July 8, 2026. https://medlineplus.gov/lab-tests/igf-1-insulin-like-growth-factor-1-test/
Mayo Clinic Laboratories. Test catalog: IGF1A – Overview: Insulin-Like Growth Factor 1, Serum, serum clinical and interpretive details. Accessed July 8, 2026. https://www.mayocliniclabs.com/test-catalog/overview/623571#clinical-and-interpretive
Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(6):1587-1609. doi:10.1210/jc.2011-0179
Danowitz M, Grimberg A. Clinical Indications for Growth Hormone Therapy. Adv Pediatr. 2022;69(1):203-217.Accessed July 8, 2026. doi:10.1016/j.yapd.2022.03.005 https://pmc.ncbi.nlm.nih.gov/articles/pmc9754707/
Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157. Accessed July 8, 2026. doi:10.2165/00063030-199912020-00007 https://pubmed.ncbi.nlm.nih.gov/18031173/
Science Media Centre. Types of scientific evidence. Published January 1, 2019. Accessed July 8, 2026. https://www.sciencemediacentre.co.nz/coveringscience/types-of-scientific-evidence/
Murphy, D. H., Schwartz, S. T., Alberts, K. O., Siegel, A. L. M., Carone, B. J., Castel, A. D., & Drolet, A. (2023). Clinically studied or clinically proven? Memory for claims in print advertisements. Applied Cognitive Psychology, 37(5), 1085–1093. Accessed July 8, 2026. https://doi.org/10.1002/acp.4106 https://onlinelibrary.wiley.com/doi/full/10.1002/acp.4106
Mayo Clinic. Drugs and supplements database: Sermorelin (injection route) – side effects & dosage. Updated February 1, 2026. Accessed July 8, 2026. https://www.mayoclinic.org/drugs-supplements/sermorelin-injection-route/description/drg-20065923
Faget KY. Telehealth practice standards with emphasis on the United States: what telerehabilitation providers need to know. Telerehabilitation. 2022;405-415. Accessed July 8, 2026. doi:10.1016/B978-0-323-82486-6.00028-9 https://pmc.ncbi.nlm.nih.gov/articles/PMC8763330/
Perrone M. FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr. PBS NewsHour. June 29, 2026. Accessed July 8, 2026. https://www.pbs.org/newshour/health/fda-panel-on-peptides-will-include-experts-who-promote-the-unproven-chemicals-favored-by-rfk-jr
World Anti-Doping Agency. Prohibited list. Published January 1, 2026. Accessed July 8, 2026. https://www.wada-ama.org/en/prohibited-list
Testing.com. IGF-1 test: What insulin-like growth factor shows. Updated November 9, 2021. Accessed July 8, 2026. https://www.testing.com/tests/insulin-growth-factor-1-igf-1/
MedlinePlus. How to understand your lab results. National Library of Medicine. Updated September 4, 2025. Accessed July 8, 2026. https://medlineplus.gov/lab-tests/how-to-understand-your-lab-results/